Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolff

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Experimental Hematology|January 1, 1979
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary reportG L Phillips, J W Fay, G P Herzig, et al.
Biorheology|February 3, 2000
The osmotic pressure of chondroitin sulphate solutions: experimental measurements and theoretical analysisS Ehrlich, N Wolff, R Schneiderman, et al.
Plos One|June 10, 2011
The strength and timing of the mitochondrial bottleneck in salmon suggests a conserved mechanism in vertebratesJonci N Wolff, Daniel J White, Michael Woodhams, et al.
Clinical Pharmacology and Therapeutics|May 1, 1982
Effects of high-dose cytarabineK R Hande, R S Stein, D A McDonough, et al.
European Journal of Biochemistry|October 29, 2000
Characterization of the internal motions of a chimeric protein by 13C NMR highlights the important dynamic consequences of the engineering on a millisecond time scaleN Wolff, M Guenneugues, B Gilquin, et al.
Cancer Treatment Reports|October 1, 1983
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lungS N Wolff, D H Johnson, K R Hande, et al.
Journal of Biomolecular NMR|July 31, 1999
Backbone NMR assignment and secondary structure of the 19 kDa hemophore HasAN Izadi-Pruneyre, N Wolff, C Castagné, et al.
Seminars in Oncology|June 1, 1985
Central nervous system toxicity with high-dose cytosine arabinosideR H Herzig, H M Lazarus, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemiaR H Herzig, H M Lazarus, S N Wolff, et al.
Cancer Treatment Reports|July 1, 1985
High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemiaR H Herzig, G L Phillips, H M Lazarus, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Experimental Hematology|January 1, 1979
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary reportG L Phillips, J W Fay, G P Herzig, et al.
Biorheology|February 3, 2000
The osmotic pressure of chondroitin sulphate solutions: experimental measurements and theoretical analysisS Ehrlich, N Wolff, R Schneiderman, et al.
Plos One|June 10, 2011
The strength and timing of the mitochondrial bottleneck in salmon suggests a conserved mechanism in vertebratesJonci N Wolff, Daniel J White, Michael Woodhams, et al.
Clinical Pharmacology and Therapeutics|May 1, 1982
Effects of high-dose cytarabineK R Hande, R S Stein, D A McDonough, et al.
European Journal of Biochemistry|October 29, 2000
Characterization of the internal motions of a chimeric protein by 13C NMR highlights the important dynamic consequences of the engineering on a millisecond time scaleN Wolff, M Guenneugues, B Gilquin, et al.
Cancer Treatment Reports|October 1, 1983
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lungS N Wolff, D H Johnson, K R Hande, et al.
Journal of Biomolecular NMR|July 31, 1999
Backbone NMR assignment and secondary structure of the 19 kDa hemophore HasAN Izadi-Pruneyre, N Wolff, C Castagné, et al.
Seminars in Oncology|June 1, 1985
Central nervous system toxicity with high-dose cytosine arabinosideR H Herzig, H M Lazarus, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemiaR H Herzig, H M Lazarus, S N Wolff, et al.
Cancer Treatment Reports|July 1, 1985
High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemiaR H Herzig, G L Phillips, H M Lazarus, et al.
Pageof 18